The cash burn contimues . The revenues contimue to slip. Instead of expensive QC's to support, you now have a phase 3 trial to fund.
The NED's have been tamed by Peter and the wolves.
If no-one is stockpiling Relenza, why should they LANI: it is no more effective: only longer lasting. All LANI is is a patent replacement for Relenza, for the time BIOTA has to compete with generics. Assuming it works, is longer lasting and does not make your dick drop off or any other unforseen side effects in the phase 3 trials.
And even if there was a bird-flu epedemic ( BIOTA's desperate hope before Relenza loses patent ) in this economic climate it probably wouldn't register.
And LANI is NOT a cure for the common cold.
Good luck , pumpers in your game of pass the parcel.
BTA Price at posting:
37.5¢ Sentiment: ST Sell Disclosure: Not Held
